The second retrospective study in 84 patients with recurrent/metastatic ACC found that median overall survival was significantly shorter in those with NOTCH1-mutated tumors compared to NOTCH1 WT malignancies (55.1 vs 204.5 months) [8]. This evidence concerns the gene NOTCH1 and adrenal cortex carcinoma.